Edition:
United States

Galena Biopharma Inc (GALE.PH)

GALE.PH on Philadelphia Stock Exchange

0.34USD
30 Sep 2016
Change (% chg)

$0.01 (+3.11%)
Prev Close
$0.33
Open
$0.34
Day's High
$0.34
Day's Low
$0.34
Volume
100
Avg. Vol
9,291
52-wk High
$2.46
52-wk Low
$0.28

Latest Key Developments (Source: Significant Developments)

Galena Biopharma reports Q2 earnings per share $0.03
Tuesday, 9 Aug 2016 04:05pm EDT 

Galena Biopharma Inc : Galena Biopharma reports second quarter 2016 financial results and provides a corporate update . Q2 earnings per share $0.03 . Q2 earnings per share $0.05 from continuing operations .Q2 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S.  Full Article

Galena Biopharma files for secondary offering of upto 3.7 mln shares - SEC filing
Monday, 25 Jul 2016 04:55pm EDT 

Galena Biopharma Inc : Galena Biopharma Inc files for secondary offering of upto 3.7 million shares of common stock - SEC filing Source: (http://bit.ly/2aeYwiV ) Further company coverage: [GALE.O] (Bengaluru Newsroom: +1 646 223 8780).  Full Article

CVI Investments reports 6.7 pct passive stake in Galena Biopharma
Friday, 15 Jul 2016 09:29am EDT 

: CVI Investments, Inc. reports 6.7 pct passive stake in Galena Biopharma as of July 8, 2016 - SEC Filing Source - http://bit.ly/29DjlAj Further company coverage: [GALE.O] (Bengaluru Newsroom; +1 646 223 8780).  Full Article

Sabby Management LLC reports 6.67 pct passive stake in Galena Biopharma
Tuesday, 12 Jul 2016 02:01pm EDT 

:Sabby Management LLC reports a passive stake of 6.67 pct in Galena Biopharma Inc as of July 8, 2016 - SEC Filing.  Full Article

Galena Biopharma says pricing of registered direct offering
Friday, 8 Jul 2016 07:05am EDT 

Galena Biopharma Inc : Galena Biopharma announces pricing of registered direct offering . Says entered into agreements with certain investors providing for issuance of 28 million shares at $0.45 per share . Offering also includes warrants to purchase up to 14 million shares of common stock with exercise price of $0.65/share .Galena Biopharma Inc says offering also has gross proceeds to company of $12.6 million.  Full Article

Galena Biopharma receives two orphan drug designations for GALE-301 and GALE-301/GALE-302
Friday, 10 Jun 2016 02:47pm EDT 

Galena Biopharma : Receives two orphan drug designations for GALE-301 and GALE-301/GALE-302 .FDA has granted two orphan-drug designations for Galena's two cancer immunotherapy peptides.  Full Article

Galena Biopharma receives fast track designation for Neuvax(tm)
Wednesday, 1 Jun 2016 07:05am EDT 

Galena Biopharma Inc :Receives fast track designation for neuvax(tm) (nelipepimut-s) present clinical trial.  Full Article

Galena Biopharma say it raised $24 mln in debt, option financing
Tuesday, 24 May 2016 12:07pm EDT 

Galena Biopharma Inc :Galena Biopharma files to say it raised $24 million in debt financing and that related to option, warrants - SEC filing.  Full Article

Galena Biopharma reports Q1 loss per share $0.90
Tuesday, 10 May 2016 04:10pm EDT 

Galena Biopharma Inc : Galena Biopharma reports first quarter 2016 financial results and provides a corporate update . Q1 loss per share $0.90 .Q1 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S.  Full Article

Galena Biopharma Inc announces proposed settlement of derivative litigation
Tuesday, 16 Feb 2016 05:00pm EST 

Galena Biopharma Inc:Announces proposed settlement of derivative litigation.Says claims alleging that certain current and former directors and officers of Galena breached their fiduciary duties.Says galena's directors' and officers' insurers have paid or caused to be paid $15 million to the company.U.S. district court for district of Oregon issued an order preliminarily approving proposed settlement by and among company.  Full Article

BRIEF-Galena Biopharma files for secondary offering of upto 14 mln shares - SEC filing

* Galena Biopharma Inc files for secondary offering of upto 14 million shares of common stock - SEC filing Source text for Eikon: (http://bit.ly/2dr9LGs) Further company coverage: